Clinical risk factors for loss of stent primary patency in patients with chronic legs ischemia

Klaudia Koza, Paweł Grzelązka, Adrianna Trofimiuk, Karol Suppan, Marcin Wasielewski, Joanna Wiśniewska, Jacek Budzyński
Advances in Clinical and Experimental Medicine  
The outcome of endovascular therapy can be influenced by a number of factors, either demographic, biochemical, angiographic or procedural. Knowledge about these factors may help in the individualization of therapeutic methods, surveillance intensity, and should, ultimately, improve intervention efficacy. The aim of this study was to estimate the effect of clinical and biochemical factors on the late outcome of lower limb artery stenting. The medical documentation of 91 patients with at least a
more » ... ts with at least a 1 year follow-up after the stenting of a lower limb artery was retrospectively evaluated. Uniand multivariate analyses were performed. Primary patency within an approximately 1.5-year follow-up amounted to 68.2%. The probability of freedom from target lesion revascularization was significantly greater in patients with dyslipidemia. According to the Cox proportional-hazards analysis, the risk of target extremity revascularization was significantly affected by the following (hazard ratio [HR], 95% confidence interval): Age (0.93, 0.88-0.99); dyslipidemia at inclusion (0.046, 0.01-0.23); LDL blood concentration (1.02; 1.01-1.04); hematocrit (1.2, 1.02-1.42); mean platelet volume (0.66, 0.44-0.99); INR (1.58, 1.13-2.21); and aPTT (1.18, 1.07-1.3). Endovascular treatment with stenting in patients with atherosclerotic peripheral arterial disease is effective, but the risk of primary patency loss was affected by the presence of dyslipidemia, age, and blood coagulation parameters. The effect of dyslipidemia on stent failure occurrence should be evaluated in further studies.
doi:10.17219/acem/58997 pmid:28791851 fatcat:uycn5e3aqjeq3cem256nsrkkua